Back to today’s briefing

Story perspectives

Americans Invest $6.2B in Diabetes Drugs Amid Medicare Negotiations

3/7/2025

50 8

Summary

Story summary

From 1980 to 2024, Americans invested $6.2 billion in diabetes and weight-loss drugs, including Ozempic and Wegovy.
A total of $11.7 billion has been allocated for developing ten high-cost prescription drugs for Medicare negotiations.
Bentley University researchers examined taxpayer funding for GLP-1 drug development, highlighting public investment in healthcare advancements.

1 of 1

Story summary

From 1980 to 2024, Americans invested $6.2 billion in diabetes and weight-loss drugs, including Ozempic and Wegovy.
A total of $11.7 billion has been allocated for developing ten high-cost prescription drugs for Medicare negotiations.
Bentley University researchers examined taxpayer funding for GLP-1 drug development, highlighting public investment in healthcare advancements.